BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 25, 2020
View Archived Issues
If a tree stings in the wood, it's with a peptide
Read More
XBiotech is developing Fluvid as novel treatment for influenza and COVID-19 coinfections
Read More
Nocion Therapeutics presents new SCN9A blockers
Read More
Roche synthesizes new antibacterial compounds
Read More
FronThera US Pharmaceuticals discloses TYK2 inhibitors
Read More
Genhouse Medicine identifies PTPN11 inhibitors
Read More
FDA clears IND for phase I trial of Emmecell's EO-2002 for corneal edema
Read More
Arthritis is different disease with antibodies than without
Read More
First data for the anti-CD73 oleclumab in triple-negative breast cancer
Read More
Results presented for ipatasertib plus abiraterone in mCRPC
Read More
Vaccination with a centrin KO Leishmania major strain is safe, immunogenic and disease-protective
Read More
Circulating DPP3 inhibition restores cardiac function during sepsis in CLP rat models
Read More
Japanese phase III study of Avigan shows promise in patients with COVID-19
Read More
First healthy volunteers dosed in phase I study of MORF-057
Read More
FDA allows IND application for TCRT-ESO-A2
Read More
Cytokinetics initiates phase I study of CK-3772271
Read More
Using tumor organoids, researchers identify recurrent, druggable neuroblastoma targets
Read More
MIL-62 demonstrates promising safety and efficacy in CD20-positive B-cell NHL
Read More
Janssen's COVID-19 vaccine candidate JNJ-78436735 enters phase III
Read More
Ensifentrine enters phase III trials for moderate to severe COPD
Read More
Millendo begins first-in-human study of MLE-301 for vasomotor symptoms in menopausal women
Read More
First-in-human data reported for MGD-019
Read More
Phase I data on NMT-cP12 support progression to phase II for severe burns
Read More
Japanese approval for Jyseleca in rheumatoid arthritis
Read More
Genfit begins phase III study of elafibranor in primary biliary cholangitis
Read More
Phase II study of semorinemab in early Alzheimer's misses key efficacy endpoints
Read More